BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26964570)

  • 1. Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2.
    Pont MJ; van der Lee DI; van der Meijden ED; van Bergen CA; Kester MG; Honders MW; Vermaat M; Eefting M; Marijt EW; Kielbasa SM; Hoen PA; Falkenburg JH; Griffioen M
    Clin Cancer Res; 2016 Aug; 22(16):4185-96. PubMed ID: 26964570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.
    Van Bergen CA; Rutten CE; Van Der Meijden ED; Van Luxemburg-Heijs SA; Lurvink EG; Houwing-Duistermaat JJ; Kester MG; Mulder A; Willemze R; Falkenburg JH; Griffioen M
    Cancer Res; 2010 Nov; 70(22):9073-83. PubMed ID: 21062987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
    Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bykova NA; Malko DB; Efimov GA
    Front Immunol; 2018; 9():1819. PubMed ID: 30166983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.
    Griffioen M; Honders MW; van der Meijden ED; van Luxemburg-Heijs SA; Lurvink EG; Kester MG; van Bergen CA; Falkenburg JH
    Haematologica; 2012 Aug; 97(8):1196-204. PubMed ID: 22419570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology Approach.
    Hombrink P; Hassan C; Kester MG; Jahn L; Pont MJ; de Ru AH; van Bergen CA; Griffioen M; Falkenburg JH; van Veelen PA; Heemskerk MH
    Clin Cancer Res; 2015 May; 21(9):2177-86. PubMed ID: 25589627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.
    Stumpf AN; van der Meijden ED; van Bergen CA; Willemze R; Falkenburg JH; Griffioen M
    Blood; 2009 Oct; 114(17):3684-92. PubMed ID: 19706888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y].
    Pilunov AM; Kuchmiy AA; Sheetikov SA; Filkin SY; Romaniuk DS; Rosov FN; Efimov GA
    Mol Biol (Mosk); 2019; 53(3):456-466. PubMed ID: 31184611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
    Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
    Front Immunol; 2020; 11():659. PubMed ID: 32362897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Multiplex Genotyping of 20 HLA-A
    Romaniuk DS; Postovskaya AM; Khmelevskaya AA; Malko DB; Efimov GA
    Front Immunol; 2019; 10():1226. PubMed ID: 31275297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
    Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
    Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
    van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
    Tykodi SS; Fujii N; Vigneron N; Lu SM; Mito JK; Miranda MX; Chou J; Voong LN; Thompson JA; Sandmaier BM; Cresswell P; Van den Eynde B; Riddell SR; Warren EH
    Clin Cancer Res; 2008 Aug; 14(16):5260-9. PubMed ID: 18698046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.
    Oosten LE; Blokland E; Kester MG; Falkenburg JH; van Halteren AG; Goulmy E
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):151-63. PubMed ID: 17241921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.
    de Rijke B; van Horssen-Zoetbrood A; Beekman JM; Otterud B; Maas F; Woestenenk R; Kester M; Leppert M; Schattenberg AV; de Witte T; van de Wiel-van Kemenade E; Dolstra H
    J Clin Invest; 2005 Dec; 115(12):3506-16. PubMed ID: 16322791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
    Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S; Baron C; Hétu F; Roy DC; Perreault C
    J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen.
    Kawase T; Akatsuka Y; Torikai H; Morishima S; Oka A; Tsujimura A; Miyazaki M; Tsujimura K; Miyamura K; Ogawa S; Inoko H; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
    Blood; 2007 Aug; 110(3):1055-63. PubMed ID: 17409267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
    Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
    Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.
    Brickner AG; Evans AM; Mito JK; Xuereb SM; Feng X; Nishida T; Fairfull L; Ferrell RE; Foon KA; Hunt DF; Shabanowitz J; Engelhard VH; Riddell SR; Warren EH
    Blood; 2006 May; 107(9):3779-86. PubMed ID: 16391015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.